# St. Charles Health System – FDA Inspection, Sep 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/st-charles-health-system/dbe090f5-cdaf-40f6-8ce3-cf6b80432e0b
Source feed: FDA_Inspections

> FDA inspection 1067783 of St. Charles Health System, September 12, 2018. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067783
- Company Name: St. Charles Health System
- Inspection Date: 2018-09-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1235464 - 2024-04-03
- FDA Inspection 929846 - 2015-06-03
- FDA Inspection 841972 - 2013-07-16
- FDA Inspection 727985 - 2011-06-03
- FDA Inspection 614226 - 2009-09-16

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kathryn-a-krentz/9523b161-3b81-4a1b-aaca-c0406d756ab4)

Company: https://www.keypedia.com/companies/st-charles-health-system/639f6c3e-12c2-4fb8-bbdb-8f2f95de2d03

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d